Exelixis | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
Agios Pharmaceuticals USD 80.87M 1.91M 2025-06
Amgen USD 8.03B 782M 2025-06
AstraZeneca USD 7.06B 1.83B 2025-06
Bayer EUR 4.56B 542M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Cytokinetics USD 74.94M 863.28M 2025-06
Eisai JPY 285.38B 19.82B 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
Exelixis USD 164.43M 19.32M 2025-06
Genmab DKK 1.3B 323M 2025-06
Glaxosmithkline GBP 3.87B 678M 2024-12
Incyte USD 2.42B 13.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.01B 622M 2025-06
Moderna USD 1.28B 344M 2025-06
Neurocrine Biosciences USD 264M 69.9M 2025-06
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.64B 208M 2025-06
Sanofi 7.44B 646M 2024-12
Takeda JPY 350.01B 35.11B 2025-06
Ultragenyx Pharmaceutical USD 166.11M 396.9M 2025-06
Xencor USD 44.44M 4.77M 2025-06


Exelixis Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.